Therapeutical approaches to transmissible spongiform encephalopathies (TSE): the case of amphotericin-B.
Calissano
M
M
Petraroli
R
R
Pocchiari
M
M
D000666:Amphotericin B / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D017096:Prion Diseases / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000666:Amphotericin B